Previous 10 | Next 10 |
home / stock / govxw / govxw news
COVID-19 Vaccine Designed as Single-Dose Against Multiple Strains Immuno-Oncology Programs Advancing ATLANTA, GA, March 23, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (NasdaqCM: GOVX), a biotechnology company developing immunotherapie...
GeoVax Chairman & CEO David Dodd to Present Corporate Overview GeoVax CSO, Mark Newman, PhD, to Participate in Immuno-Oncology Panel Discussion ATLANTA, GA, March 17, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc . (NasdaqCM: GOVX) (...
Conference call to be held Wednesday, March 24, at 8:00 a.m. Eastern Time ATLANTA, GA, March 15, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (NasdaqCM: GOVX), a biotechnology company developing human immunotherapies and vaccines against infectious dise...
Filings Made in Corporate Focus Areas of SARS-CoV-2 and Immuno-Oncology Atlanta, GA, March 04, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (NasdaqCM: GOVX) (“GeoVax” or the “Company”), a biotechnology company developin...
Virtual Conference to be Held March 9-10, 2021 ATLANTA, GA, March 03, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc . (NasdaqCM: GOVX), a biotechnology company developing vaccines and immunotherapies against infectious diseases and cancers, announced ...
Meet with GeoVax CEO David Dodd & CFO Mark Reynolds who will Deliver a Presentation Titled “ Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond ” ATLANTA, GA, March 01, 2021 (GLOBE NEWSWIRE) -- via NewMedi...
Atlanta, GA, Feb. 11, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (NasdaqCM: GOVX) (“GeoVax” or the “Company”), a biotechnology company developing human immunotherapies and vaccines against infectious diseases and cancer, today announce...
ATLANTA, GA, Feb. 08, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (Nasdaq: GOVX) (“GeoVax” or the “Company”), a biotechnology company developing human immunotherapies and vaccines against infectious diseases and cancer, today announ...
Company Focused on Single-dose Vaccine Against Multiple COVID Strains ATLANTA, GA, Jan. 11, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc . (NasdaqCM: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and...
GeoVax Also Participating in BIO@JPM During “J.P. Morgan Week 2021” ATLANTA, GA, Jan. 05, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc . (NasdaqCM: GOVX), a biotechnology company developing vaccines and immunotherapies against infecti...
News, Short Squeeze, Breakout and More Instantly...
GeoVax Labs Inc. Warrants Company Name:
GOVXW Stock Symbol:
NASDAQ Market:
GeoVax Labs Inc. Warrants Website:
Presentation Made During the 24th Annual World Vaccine Congress ATLANTA, GA, April 04, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced ...
ATLANTA, GA, March 28, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced that its Chief Scientific Officer, Mark Newman, PhD, will presen...
ATLANTA, GA, March 12, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, announced today that its Chairman and CEO, David Dodd, will present at the 36t...